QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 限定条件 发表日期：2011     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 The epigenetic modifier PRDM5 functions as a tumor suppressor through modulating WNT/beta-catenin signaling and is frequently silenced in multiple tumors. 期刊论文 PLOS ONE, 2011, 卷号: 6, 期号: 11, 页码: e27346 作者:  Shu, Xing-sheng*;  Geng, Hua;  Li, Lili;  Ying, Jianming;  Ma, Chunhong 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/03 DNA methylation,Epigenetics,Methylation,Cellular stress responses,Oncogenes,Polymerase chain reaction,Carcinomas,Oncogenic signaling   The Epigenetic Modifier PRDM5 Functions as a Tumor Suppressor through Modulating WNT/beta-Catenin Signaling and Is Frequently Silenced in Multiple Tumors 期刊论文 PLOS ONE, 2011, 卷号: 6, 期号: 11 作者:  Shu, Xing-sheng;  Geng, Hua;  Li, Lili;  Ying, Jianming;  Ma, Chunhong 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/23 Lapatinib plus capecitabine in treating HER2-positive advanced breast cancer: efficacy, safety, and biomarker results from Chinese patients 期刊论文 2011, 卷号: 30, 期号: 5, 页码: 327-35 作者:  Xu Bing-He;  Jiang Ze-Fei;  Chua Daniel;  Shao Zhi-Min;  Luo Rong-Cheng 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13 Lapatinib  capecitabine  HER2  metastatic breast cancer